Patents
Literature
3 results about "Solifenacin Succinate" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
A quinuclidine and tetrahydroisoquinoline derivative and selective M3 MUSCARINIC ANTAGONIST. It is used as a UROLOGIC AGENT in the treatment of URINARY INCONTINENCE.
Solifenacin succinate bilayer tablet formulation
PCT designated stageWO2026135587A1Organic active ingredientsAerosol deliverySolifenacin SuccinateImmediate release
The present invention relates to pharmaceutical compositions, specifically bilayer tablet formulations containing mirabegron and solifenacin succinate. The invention particularly addresses improvements in in-vitro release of solifenacin succinate in immediate release layer by improved manufacturing processes.
Owner:SANTA FARMA ILAC SANAYII ANONIM SIRKETI
A solifenacin succinate tablet composition and a preparation method thereof
ActiveCN117205166BInorganic non-active ingredientsPill deliverySolifenacin SuccinateSodium phosphates
A solifenacin succinate pharmaceutical composition comprises solifenacin succinate 5mg, sodium hexametaphosphate 0.25-0.75mg, sorbitol 72-108mg, microcrystalline cellulose 36-72mg, magnesium stearate 0.75-2.25mg. The solifenacin succinate pharmaceutical composition has high stability, reduces the generation of impurity I, and has good total mixture material fluidity, effectively improving the content uniformity.
Owner:DISHA PHARMA GRP
Mirabegron and solifenacin bilayer tablet
PCT designated stageWO2026135586A1Organic active ingredientsPill deliverySolifenacin SuccinatePharmaceutical drug
The present invention relates to bilayer tablet pharmaceutical compositions comprising an immediate-release layer comprising solifenacin succinate as active ingredient, a binder, a distintegrant and at least one pharmaceutically acceptable excipient, a prolonged-release layer comprising mirabegron as active substance and at least one pharmaceutically acceptable excipient.
Owner:SANTA FARMA ILAC SANAYII ANONIM SIRKETI